Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityNo recent work listed

Xiaofei Xin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7618-0808; OpenAlex author ID A5020199916. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper

Papers 2

  1. Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy. Co-author DOI 10.1126/sciadv.abd6764↗
  2. ROS-Responsive Polymeric Micelles for Triggered Simultaneous Delivery of PLK1 Inhibitor/miR-34a and Effective Synergistic Therapy in Pancreatic Cancer. Co-author DOI 10.1021/acsami.9b02756↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ram I. Mahato · 2 shared papers, 2019–2020 · strength 0.24
  2. Virender Kumar · 1 shared paper, 2020 · strength 0.12
  3. Rajan Sharma Bhattarai · 1 shared paper, 2020 · strength 0.12
  4. Vinod Kumar · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.